OOIR: Observatory of International Research

Papers

(The H4-Index of Neoplasia is 31. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)

Article	Citations
Filamin a binds deleted in liver cancer 1 (DLC1) to promote its tumor suppressor activity and inhibit the SRF coactivator MRTF-A	75
Visualizing mast cell migration to tumor sites using sodium iodide symporter of nuclear medicine reporter gene	70
Sialylated IgG-activated integrin β4-Src-Erk axis stabilizes c-Myc in a p300 lysine acetyltransferase-dependent manner to promote colorectal cancer liver metastasis	68
5-Aza-2′-deoxycytidin (Decitabine) increases cancer-testis antigen expression in head and neck squamous cell carcinoma and modifies immune checkpoint expression, especially in CD39-positive CD8 and CD	67
Corrigendum to “Structure-function studies of the bHLH phosphorylation domain of TWIST1 in prostate cancer cells” [Neoplasia 17 (2014) 85]	65
Identification of molecularly targeted therapy-induced immunopeptidome in diffuse midline glioma (DMG)	55
Corrigendum to “Tumorigenicity of IL-1α- and IL-1β-Deficient Fibrosarcoma Cells” [Neoplasia, Volume 10, Issue 6, June 2008, Pages 549–562]	55
ARID1A loss sensitizes colorectal cancer cells to floxuridine	53
L-methionine promotes CD8+ T cells killing hepatocellular carcinoma by inhibiting NR1I2/PCSK9 signaling	53
Epitranscriptomic mechanisms of androgen signalling and prostate cancer	49
DHX34 deficiency triggers tumor-intrinsic immunity via a dsRNA-mediated type I interferon pathway activation in HCC	48
Therapeutic benefit of the dual ALK/FAK inhibitor ESK440 in ALK-driven neuroblastoma	47
Single cell analysis unveils the commonality and heterogeneity between nasopharyngeal and oropharyngeal carcinoma	45
High metastatic tumor-derived CXCL16 mediates liver colonization metastasis by inducing Kupffer cell polarization via the PI3K/AKT/FOXO3a pathway	44
Mutational signatures and their association with survival and gene expression in urological carcinomas	43
Combination of sunitinib and 177Lu-labeled antibody cG250 targeted radioimmunotherapy: A promising new therapeutic strategy for patients with advanced renal cell cancer	43
Combined radio-immunotherapy: An opportunity to increase the therapeutic ratio of oligometastasis-directed radiotherapy	43
Retraction notice to “Role of Autophagy as a Survival Mechanism for Hypoxic Cells in Tumors” [Neoplasia 18 (2016) 347- 355/201]	41
Tumor-Infiltrating Immune Cells in Colorectal Cancer	40
Time-restricted feeding affects the fecal microbiome metabolome and its diurnal oscillations in lung cancer mice	38
BPGM as an intrinsic brake to constrain metastasis through phospho-epigenetic-mediated carnitine biosynthesis suppression	37
RUNX2 enhances bladder cancer progression by promoting glutamine metabolism	35
Myxoid glioneuronal tumor: Histopathologic, neuroradiologic, and molecular features in a single center series	34
CCAAT‐enhancer binding protein delta functions as a tumor suppressor gene in acute myeloid leukemia	34
Regulatory mechanisms of the Hippo/YAP axis by G-protein coupled estrogen receptor in gastric signet-ring cell carcinoma	33

From adenoma to CRC stages: the oral-gut microbiome axis as a source of potential microbial and metabolic biomarkers of malignancy	33
New horizons in B-cell lymphoma immunotherapy: From immune checkpoints to precision medicine	33
Identification of recurrent BRAF non-V600 mutations in intraductal carcinoma of the prostate in Chinese populations	32
Rezatapopt: A promising small-molecule “refolder” specific for TP53Y220C mutant tumors	32
A spatiotemporal atlas of orchiectomy-induced androgen deprivation-mediated modulation of cellular composition and gene expression in the mouse prostate	31
Advanced progress of spatial metabolomics in head and neck cancer research	31